Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Shirane M, Yawata N, Motooka D, Shibata K, Khor SS, Omae Y, Kaburaki T, Yanai R, Mashimo H, Yamana S, Ito T, Hayashida A, Mori Y, Numata A, Murakami Y, Fujiwara K, Ohguro N, Hosogai M, Akiyama M, Hasegawa E, Paley M, Takeda A, Maenaka K, Akashi K, Yokoyama WM, Tokunaga K, Yawata M, Sonoda KH. Shirane M, et al. Among authors: ohguro n. Front Immunol. 2023 Jan 5;13:1124440. doi: 10.3389/fimmu.2022.1124440. eCollection 2022. Front Immunol. 2023. PMID: 36685570 Free PMC article.
Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Shirane M, Yawata N, Motooka D, Shibata K, Khor SS, Omae Y, Kaburaki T, Yanai R, Mashimo H, Yamana S, Ito T, Hayashida A, Mori Y, Numata A, Murakami Y, Fujiwara K, Ohguro N, Hosogai M, Akiyama M, Hasegawa E, Paley M, Takeda A, Maenaka K, Akashi K, Yokoyama WM, Tokunaga K, Yawata M, Sonoda KH. Shirane M, et al. Among authors: ohguro n. Front Immunol. 2022 Oct 19;13:1008220. doi: 10.3389/fimmu.2022.1008220. eCollection 2022. Front Immunol. 2022. PMID: 36341392 Free PMC article.
Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study.
Takeuchi M, Usui Y, Namba K, Keino H, Takeuchi M, Takase H, Kamoi K, Hase K, Ito T, Nakai K, Maruyama K, Kobayashi E, Mashimo H, Sato T, Ohguro N, Hori J, Okada AA, Sonoda KH, Mizuki N, Goto H. Takeuchi M, et al. Among authors: ohguro n. Front Med (Lausanne). 2023 Jan 20;10:1095423. doi: 10.3389/fmed.2023.1095423. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36744150 Free PMC article.
A multicenter study of ocular inflammation after COVID-19 vaccination.
Yasaka Y, Hasegawa E, Keino H, Usui Y, Maruyama K, Yamamoto Y, Kaburaki T, Iwata D, Takeuchi M, Kusuhara S, Takase H, Nagata K, Yanai R, Kaneko Y, Iwahashi C, Fukushima A, Ohguro N, Sonoda KH; JOIS Uveitis Survey Working Group. Yasaka Y, et al. Among authors: ohguro n. Jpn J Ophthalmol. 2023 Jan;67(1):14-21. doi: 10.1007/s10384-022-00962-9. Epub 2022 Nov 22. Jpn J Ophthalmol. 2023. PMID: 36417027 Free PMC article.
Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt-Koyanagi-Harada disease.
Ono T, Goto H, Sakai T, Nitta F, Mizuki N, Takase H, Kaneko Y, Hori J, Nakano S, Nao-I N, Ohguro N, Miyata K, Tomita M, Mochizuki M; Japan VKH Disease Treatment Study Group. Ono T, et al. Among authors: ohguro n. Jpn J Ophthalmol. 2022 Mar;66(2):119-129. doi: 10.1007/s10384-021-00878-w. Epub 2021 Oct 24. Jpn J Ophthalmol. 2022. PMID: 34689288 Clinical Trial.
94 results